Medical Devices & Consumables
Global Blood Compatible Nanocoating Market Research Report 2025
- Nov 18, 25
- ID: 607223
- Pages: 80
- Figures: 75
- Views: 1
This report aims to provide a comprehensive presentation of the global market for Blood Compatible Nanocoating, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Compatible Nanocoating.
The Blood Compatible Nanocoating market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Compatible Nanocoating market comprehensively. Regional market sizes, concerning products by Type, by Application, by Functional Property and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Compatible Nanocoating companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Surmodics
Hemoteq AG (Freudenberg)
Biocoat
Covalon Technologies
Nanova Biomaterials
DSM Biomedical
NANOCOAT Medical
Harland Medical Systems
Daikin Industries
Applied Medical Coatings
Segment by Type
Inorganic Nanocoatings
Polymeric Nanocoatings
Hybrid or Composite Nanocoatings
Segment by Functional Property
Antithrombogenic
Anti-Fouling
Antimicrobial
Segment by Application Area
Cardiovascular Devices
Renal & Dialysis Devices
Neurovascular Implants
Orthopedic Implants
Catheters & Guidewires
Surgical/Extracorporeal Devices
Segment by Application
Medical Device Manufacturers
R&D and Material Companies
Hospitals & Research Institutes
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Functional Property etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Compatible Nanocoating company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Blood Compatible Nanocoating market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Compatible Nanocoating market comprehensively. Regional market sizes, concerning products by Type, by Application, by Functional Property and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Compatible Nanocoating companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Surmodics
Hemoteq AG (Freudenberg)
Biocoat
Covalon Technologies
Nanova Biomaterials
DSM Biomedical
NANOCOAT Medical
Harland Medical Systems
Daikin Industries
Applied Medical Coatings
Segment by Type
Inorganic Nanocoatings
Polymeric Nanocoatings
Hybrid or Composite Nanocoatings
Segment by Functional Property
Antithrombogenic
Anti-Fouling
Antimicrobial
Segment by Application Area
Cardiovascular Devices
Renal & Dialysis Devices
Neurovascular Implants
Orthopedic Implants
Catheters & Guidewires
Surgical/Extracorporeal Devices
Segment by Application
Medical Device Manufacturers
R&D and Material Companies
Hospitals & Research Institutes
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Functional Property etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Compatible Nanocoating company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Compatible Nanocoating Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inorganic Nanocoatings
1.2.3 Polymeric Nanocoatings
1.2.4 Hybrid or Composite Nanocoatings
1.3 Market by Functional Property
1.3.1 Global Blood Compatible Nanocoating Market Size Growth Rate by Functional Property: 2020 VS 2024 VS 2031
1.3.2 Antithrombogenic
1.3.3 Anti-Fouling
1.3.4 Antimicrobial
1.4 Market by Application Area
1.4.1 Global Blood Compatible Nanocoating Market Size Growth Rate by Application Area: 2020 VS 2024 VS 2031
1.4.2 Cardiovascular Devices
1.4.3 Renal & Dialysis Devices
1.4.4 Neurovascular Implants
1.4.5 Orthopedic Implants
1.4.6 Catheters & Guidewires
1.4.7 Surgical/Extracorporeal Devices
1.5 Market by Application
1.5.1 Global Blood Compatible Nanocoating Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Medical Device Manufacturers
1.5.3 R&D and Material Companies
1.5.4 Hospitals & Research Institutes
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Blood Compatible Nanocoating Market Perspective (2020-2031)
2.2 Global Blood Compatible Nanocoating Growth Trends by Region
2.2.1 Global Blood Compatible Nanocoating Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Blood Compatible Nanocoating Historic Market Size by Region (2020-2025)
2.2.3 Blood Compatible Nanocoating Forecasted Market Size by Region (2026-2031)
2.3 Blood Compatible Nanocoating Market Dynamics
2.3.1 Blood Compatible Nanocoating Industry Trends
2.3.2 Blood Compatible Nanocoating Market Drivers
2.3.3 Blood Compatible Nanocoating Market Challenges
2.3.4 Blood Compatible Nanocoating Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Compatible Nanocoating Players by Revenue
3.1.1 Global Top Blood Compatible Nanocoating Players by Revenue (2020-2025)
3.1.2 Global Blood Compatible Nanocoating Revenue Market Share by Players (2020-2025)
3.2 Global Top Blood Compatible Nanocoating Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Blood Compatible Nanocoating Revenue
3.4 Global Blood Compatible Nanocoating Market Concentration Ratio
3.4.1 Global Blood Compatible Nanocoating Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Compatible Nanocoating Revenue in 2024
3.5 Global Key Players of Blood Compatible Nanocoating Head office and Area Served
3.6 Global Key Players of Blood Compatible Nanocoating, Product and Application
3.7 Global Key Players of Blood Compatible Nanocoating, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Compatible Nanocoating Breakdown Data by Type
4.1 Global Blood Compatible Nanocoating Historic Market Size by Type (2020-2025)
4.2 Global Blood Compatible Nanocoating Forecasted Market Size by Type (2026-2031)
5 Blood Compatible Nanocoating Breakdown Data by Application
5.1 Global Blood Compatible Nanocoating Historic Market Size by Application (2020-2025)
5.2 Global Blood Compatible Nanocoating Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Blood Compatible Nanocoating Market Size (2020-2031)
6.2 North America Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Blood Compatible Nanocoating Market Size by Country (2020-2025)
6.4 North America Blood Compatible Nanocoating Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Compatible Nanocoating Market Size (2020-2031)
7.2 Europe Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Blood Compatible Nanocoating Market Size by Country (2020-2025)
7.4 Europe Blood Compatible Nanocoating Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Blood Compatible Nanocoating Market Size (2020-2031)
8.2 Asia-Pacific Blood Compatible Nanocoating Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2020-2025)
8.4 Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Blood Compatible Nanocoating Market Size (2020-2031)
9.2 Latin America Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Blood Compatible Nanocoating Market Size by Country (2020-2025)
9.4 Latin America Blood Compatible Nanocoating Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Compatible Nanocoating Market Size (2020-2031)
10.2 Middle East & Africa Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2020-2025)
10.4 Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Surmodics
11.1.1 Surmodics Company Details
11.1.2 Surmodics Business Overview
11.1.3 Surmodics Blood Compatible Nanocoating Introduction
11.1.4 Surmodics Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.1.5 Surmodics Recent Development
11.2 Hemoteq AG (Freudenberg)
11.2.1 Hemoteq AG (Freudenberg) Company Details
11.2.2 Hemoteq AG (Freudenberg) Business Overview
11.2.3 Hemoteq AG (Freudenberg) Blood Compatible Nanocoating Introduction
11.2.4 Hemoteq AG (Freudenberg) Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.2.5 Hemoteq AG (Freudenberg) Recent Development
11.3 Biocoat
11.3.1 Biocoat Company Details
11.3.2 Biocoat Business Overview
11.3.3 Biocoat Blood Compatible Nanocoating Introduction
11.3.4 Biocoat Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.3.5 Biocoat Recent Development
11.4 Covalon Technologies
11.4.1 Covalon Technologies Company Details
11.4.2 Covalon Technologies Business Overview
11.4.3 Covalon Technologies Blood Compatible Nanocoating Introduction
11.4.4 Covalon Technologies Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.4.5 Covalon Technologies Recent Development
11.5 Nanova Biomaterials
11.5.1 Nanova Biomaterials Company Details
11.5.2 Nanova Biomaterials Business Overview
11.5.3 Nanova Biomaterials Blood Compatible Nanocoating Introduction
11.5.4 Nanova Biomaterials Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.5.5 Nanova Biomaterials Recent Development
11.6 DSM Biomedical
11.6.1 DSM Biomedical Company Details
11.6.2 DSM Biomedical Business Overview
11.6.3 DSM Biomedical Blood Compatible Nanocoating Introduction
11.6.4 DSM Biomedical Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.6.5 DSM Biomedical Recent Development
11.7 NANOCOAT Medical
11.7.1 NANOCOAT Medical Company Details
11.7.2 NANOCOAT Medical Business Overview
11.7.3 NANOCOAT Medical Blood Compatible Nanocoating Introduction
11.7.4 NANOCOAT Medical Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.7.5 NANOCOAT Medical Recent Development
11.8 Harland Medical Systems
11.8.1 Harland Medical Systems Company Details
11.8.2 Harland Medical Systems Business Overview
11.8.3 Harland Medical Systems Blood Compatible Nanocoating Introduction
11.8.4 Harland Medical Systems Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.8.5 Harland Medical Systems Recent Development
11.9 Daikin Industries
11.9.1 Daikin Industries Company Details
11.9.2 Daikin Industries Business Overview
11.9.3 Daikin Industries Blood Compatible Nanocoating Introduction
11.9.4 Daikin Industries Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.9.5 Daikin Industries Recent Development
11.10 Applied Medical Coatings
11.10.1 Applied Medical Coatings Company Details
11.10.2 Applied Medical Coatings Business Overview
11.10.3 Applied Medical Coatings Blood Compatible Nanocoating Introduction
11.10.4 Applied Medical Coatings Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.10.5 Applied Medical Coatings Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Compatible Nanocoating Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inorganic Nanocoatings
1.2.3 Polymeric Nanocoatings
1.2.4 Hybrid or Composite Nanocoatings
1.3 Market by Functional Property
1.3.1 Global Blood Compatible Nanocoating Market Size Growth Rate by Functional Property: 2020 VS 2024 VS 2031
1.3.2 Antithrombogenic
1.3.3 Anti-Fouling
1.3.4 Antimicrobial
1.4 Market by Application Area
1.4.1 Global Blood Compatible Nanocoating Market Size Growth Rate by Application Area: 2020 VS 2024 VS 2031
1.4.2 Cardiovascular Devices
1.4.3 Renal & Dialysis Devices
1.4.4 Neurovascular Implants
1.4.5 Orthopedic Implants
1.4.6 Catheters & Guidewires
1.4.7 Surgical/Extracorporeal Devices
1.5 Market by Application
1.5.1 Global Blood Compatible Nanocoating Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Medical Device Manufacturers
1.5.3 R&D and Material Companies
1.5.4 Hospitals & Research Institutes
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Blood Compatible Nanocoating Market Perspective (2020-2031)
2.2 Global Blood Compatible Nanocoating Growth Trends by Region
2.2.1 Global Blood Compatible Nanocoating Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Blood Compatible Nanocoating Historic Market Size by Region (2020-2025)
2.2.3 Blood Compatible Nanocoating Forecasted Market Size by Region (2026-2031)
2.3 Blood Compatible Nanocoating Market Dynamics
2.3.1 Blood Compatible Nanocoating Industry Trends
2.3.2 Blood Compatible Nanocoating Market Drivers
2.3.3 Blood Compatible Nanocoating Market Challenges
2.3.4 Blood Compatible Nanocoating Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Compatible Nanocoating Players by Revenue
3.1.1 Global Top Blood Compatible Nanocoating Players by Revenue (2020-2025)
3.1.2 Global Blood Compatible Nanocoating Revenue Market Share by Players (2020-2025)
3.2 Global Top Blood Compatible Nanocoating Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Blood Compatible Nanocoating Revenue
3.4 Global Blood Compatible Nanocoating Market Concentration Ratio
3.4.1 Global Blood Compatible Nanocoating Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Compatible Nanocoating Revenue in 2024
3.5 Global Key Players of Blood Compatible Nanocoating Head office and Area Served
3.6 Global Key Players of Blood Compatible Nanocoating, Product and Application
3.7 Global Key Players of Blood Compatible Nanocoating, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Compatible Nanocoating Breakdown Data by Type
4.1 Global Blood Compatible Nanocoating Historic Market Size by Type (2020-2025)
4.2 Global Blood Compatible Nanocoating Forecasted Market Size by Type (2026-2031)
5 Blood Compatible Nanocoating Breakdown Data by Application
5.1 Global Blood Compatible Nanocoating Historic Market Size by Application (2020-2025)
5.2 Global Blood Compatible Nanocoating Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Blood Compatible Nanocoating Market Size (2020-2031)
6.2 North America Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Blood Compatible Nanocoating Market Size by Country (2020-2025)
6.4 North America Blood Compatible Nanocoating Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Compatible Nanocoating Market Size (2020-2031)
7.2 Europe Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Blood Compatible Nanocoating Market Size by Country (2020-2025)
7.4 Europe Blood Compatible Nanocoating Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Blood Compatible Nanocoating Market Size (2020-2031)
8.2 Asia-Pacific Blood Compatible Nanocoating Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2020-2025)
8.4 Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Blood Compatible Nanocoating Market Size (2020-2031)
9.2 Latin America Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Blood Compatible Nanocoating Market Size by Country (2020-2025)
9.4 Latin America Blood Compatible Nanocoating Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Compatible Nanocoating Market Size (2020-2031)
10.2 Middle East & Africa Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2020-2025)
10.4 Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Surmodics
11.1.1 Surmodics Company Details
11.1.2 Surmodics Business Overview
11.1.3 Surmodics Blood Compatible Nanocoating Introduction
11.1.4 Surmodics Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.1.5 Surmodics Recent Development
11.2 Hemoteq AG (Freudenberg)
11.2.1 Hemoteq AG (Freudenberg) Company Details
11.2.2 Hemoteq AG (Freudenberg) Business Overview
11.2.3 Hemoteq AG (Freudenberg) Blood Compatible Nanocoating Introduction
11.2.4 Hemoteq AG (Freudenberg) Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.2.5 Hemoteq AG (Freudenberg) Recent Development
11.3 Biocoat
11.3.1 Biocoat Company Details
11.3.2 Biocoat Business Overview
11.3.3 Biocoat Blood Compatible Nanocoating Introduction
11.3.4 Biocoat Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.3.5 Biocoat Recent Development
11.4 Covalon Technologies
11.4.1 Covalon Technologies Company Details
11.4.2 Covalon Technologies Business Overview
11.4.3 Covalon Technologies Blood Compatible Nanocoating Introduction
11.4.4 Covalon Technologies Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.4.5 Covalon Technologies Recent Development
11.5 Nanova Biomaterials
11.5.1 Nanova Biomaterials Company Details
11.5.2 Nanova Biomaterials Business Overview
11.5.3 Nanova Biomaterials Blood Compatible Nanocoating Introduction
11.5.4 Nanova Biomaterials Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.5.5 Nanova Biomaterials Recent Development
11.6 DSM Biomedical
11.6.1 DSM Biomedical Company Details
11.6.2 DSM Biomedical Business Overview
11.6.3 DSM Biomedical Blood Compatible Nanocoating Introduction
11.6.4 DSM Biomedical Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.6.5 DSM Biomedical Recent Development
11.7 NANOCOAT Medical
11.7.1 NANOCOAT Medical Company Details
11.7.2 NANOCOAT Medical Business Overview
11.7.3 NANOCOAT Medical Blood Compatible Nanocoating Introduction
11.7.4 NANOCOAT Medical Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.7.5 NANOCOAT Medical Recent Development
11.8 Harland Medical Systems
11.8.1 Harland Medical Systems Company Details
11.8.2 Harland Medical Systems Business Overview
11.8.3 Harland Medical Systems Blood Compatible Nanocoating Introduction
11.8.4 Harland Medical Systems Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.8.5 Harland Medical Systems Recent Development
11.9 Daikin Industries
11.9.1 Daikin Industries Company Details
11.9.2 Daikin Industries Business Overview
11.9.3 Daikin Industries Blood Compatible Nanocoating Introduction
11.9.4 Daikin Industries Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.9.5 Daikin Industries Recent Development
11.10 Applied Medical Coatings
11.10.1 Applied Medical Coatings Company Details
11.10.2 Applied Medical Coatings Business Overview
11.10.3 Applied Medical Coatings Blood Compatible Nanocoating Introduction
11.10.4 Applied Medical Coatings Revenue in Blood Compatible Nanocoating Business (2020-2025)
11.10.5 Applied Medical Coatings Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Blood Compatible Nanocoating Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Inorganic Nanocoatings
Table 3. Key Players of Polymeric Nanocoatings
Table 4. Key Players of Hybrid or Composite Nanocoatings
Table 5. Global Blood Compatible Nanocoating Market Size Growth Rate by Functional Property (US$ Million): 2020 VS 2024 VS 2031
Table 6. Key Players of Antithrombogenic
Table 7. Key Players of Anti-Fouling
Table 8. Key Players of Antimicrobial
Table 9. Global Blood Compatible Nanocoating Market Size Growth Rate by Application Area (US$ Million): 2020 VS 2024 VS 2031
Table 10. Key Players of Cardiovascular Devices
Table 11. Key Players of Renal & Dialysis Devices
Table 12. Key Players of Neurovascular Implants
Table 13. Key Players of Orthopedic Implants
Table 14. Key Players of Catheters & Guidewires
Table 15. Key Players of Surgical/Extracorporeal Devices
Table 16. Global Blood Compatible Nanocoating Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Blood Compatible Nanocoating Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Blood Compatible Nanocoating Market Size by Region (2020-2025) & (US$ Million)
Table 19. Global Blood Compatible Nanocoating Market Share by Region (2020-2025)
Table 20. Global Blood Compatible Nanocoating Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 21. Global Blood Compatible Nanocoating Market Share by Region (2026-2031)
Table 22. Blood Compatible Nanocoating Market Trends
Table 23. Blood Compatible Nanocoating Market Drivers
Table 24. Blood Compatible Nanocoating Market Challenges
Table 25. Blood Compatible Nanocoating Market Restraints
Table 26. Global Blood Compatible Nanocoating Revenue by Players (2020-2025) & (US$ Million)
Table 27. Global Blood Compatible Nanocoating Market Share by Players (2020-2025)
Table 28. Global Top Blood Compatible Nanocoating Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Compatible Nanocoating as of 2024)
Table 29. Ranking of Global Top Blood Compatible Nanocoating Companies by Revenue (US$ Million) in 2024
Table 30. Global 5 Largest Players Market Share by Blood Compatible Nanocoating Revenue (CR5 and HHI) & (2020-2025)
Table 31. Global Key Players of Blood Compatible Nanocoating, Headquarters and Area Served
Table 32. Global Key Players of Blood Compatible Nanocoating, Product and Application
Table 33. Global Key Players of Blood Compatible Nanocoating, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Blood Compatible Nanocoating Market Size by Type (2020-2025) & (US$ Million)
Table 36. Global Blood Compatible Nanocoating Revenue Market Share by Type (2020-2025)
Table 37. Global Blood Compatible Nanocoating Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 38. Global Blood Compatible Nanocoating Revenue Market Share by Type (2026-2031)
Table 39. Global Blood Compatible Nanocoating Market Size by Application (2020-2025) & (US$ Million)
Table 40. Global Blood Compatible Nanocoating Revenue Market Share by Application (2020-2025)
Table 41. Global Blood Compatible Nanocoating Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 42. Global Blood Compatible Nanocoating Revenue Market Share by Application (2026-2031)
Table 43. North America Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. North America Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)
Table 45. North America Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)
Table 46. Europe Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Europe Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)
Table 48. Europe Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)
Table 49. Asia-Pacific Blood Compatible Nanocoating Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 50. Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2020-2025) & (US$ Million)
Table 51. Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2026-2031) & (US$ Million)
Table 52. Latin America Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 53. Latin America Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)
Table 54. Latin America Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)
Table 55. Middle East & Africa Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 56. Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)
Table 57. Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)
Table 58. Surmodics Company Details
Table 59. Surmodics Business Overview
Table 60. Surmodics Blood Compatible Nanocoating Product
Table 61. Surmodics Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 62. Surmodics Recent Development
Table 63. Hemoteq AG (Freudenberg) Company Details
Table 64. Hemoteq AG (Freudenberg) Business Overview
Table 65. Hemoteq AG (Freudenberg) Blood Compatible Nanocoating Product
Table 66. Hemoteq AG (Freudenberg) Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 67. Hemoteq AG (Freudenberg) Recent Development
Table 68. Biocoat Company Details
Table 69. Biocoat Business Overview
Table 70. Biocoat Blood Compatible Nanocoating Product
Table 71. Biocoat Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 72. Biocoat Recent Development
Table 73. Covalon Technologies Company Details
Table 74. Covalon Technologies Business Overview
Table 75. Covalon Technologies Blood Compatible Nanocoating Product
Table 76. Covalon Technologies Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 77. Covalon Technologies Recent Development
Table 78. Nanova Biomaterials Company Details
Table 79. Nanova Biomaterials Business Overview
Table 80. Nanova Biomaterials Blood Compatible Nanocoating Product
Table 81. Nanova Biomaterials Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 82. Nanova Biomaterials Recent Development
Table 83. DSM Biomedical Company Details
Table 84. DSM Biomedical Business Overview
Table 85. DSM Biomedical Blood Compatible Nanocoating Product
Table 86. DSM Biomedical Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 87. DSM Biomedical Recent Development
Table 88. NANOCOAT Medical Company Details
Table 89. NANOCOAT Medical Business Overview
Table 90. NANOCOAT Medical Blood Compatible Nanocoating Product
Table 91. NANOCOAT Medical Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 92. NANOCOAT Medical Recent Development
Table 93. Harland Medical Systems Company Details
Table 94. Harland Medical Systems Business Overview
Table 95. Harland Medical Systems Blood Compatible Nanocoating Product
Table 96. Harland Medical Systems Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 97. Harland Medical Systems Recent Development
Table 98. Daikin Industries Company Details
Table 99. Daikin Industries Business Overview
Table 100. Daikin Industries Blood Compatible Nanocoating Product
Table 101. Daikin Industries Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 102. Daikin Industries Recent Development
Table 103. Applied Medical Coatings Company Details
Table 104. Applied Medical Coatings Business Overview
Table 105. Applied Medical Coatings Blood Compatible Nanocoating Product
Table 106. Applied Medical Coatings Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 107. Applied Medical Coatings Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Blood Compatible Nanocoating Picture
Figure 2. Global Blood Compatible Nanocoating Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Blood Compatible Nanocoating Market Share by Type: 2024 VS 2031
Figure 4. Inorganic Nanocoatings Features
Figure 5. Polymeric Nanocoatings Features
Figure 6. Hybrid or Composite Nanocoatings Features
Figure 7. Global Blood Compatible Nanocoating Market Size Comparison by Functional Property (2020-2031) & (US$ Million)
Figure 8. Antithrombogenic Features
Figure 9. Anti-Fouling Features
Figure 10. Antimicrobial Features
Figure 11. Global Blood Compatible Nanocoating Market Size Comparison by Application Area (2020-2031) & (US$ Million)
Figure 12. Cardiovascular Devices Features
Figure 13. Renal & Dialysis Devices Features
Figure 14. Neurovascular Implants Features
Figure 15. Orthopedic Implants Features
Figure 16. Catheters & Guidewires Features
Figure 17. Surgical/Extracorporeal Devices Features
Figure 18. Global Blood Compatible Nanocoating Market Size by Application (2020-2031) & (US$ Million)
Figure 19. Global Blood Compatible Nanocoating Market Share by Application: 2024 VS 2031
Figure 20. Medical Device Manufacturers Case Studies
Figure 21. R&D and Material Companies Case Studies
Figure 22. Hospitals & Research Institutes Case Studies
Figure 23. Blood Compatible Nanocoating Report Years Considered
Figure 24. Global Blood Compatible Nanocoating Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 25. Global Blood Compatible Nanocoating Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 26. Global Blood Compatible Nanocoating Market Share by Region: 2024 VS 2031
Figure 27. Global Blood Compatible Nanocoating Market Share by Players in 2024
Figure 28. Global Blood Compatible Nanocoating Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 29. The Top 10 and 5 Players Market Share by Blood Compatible Nanocoating Revenue in 2024
Figure 30. North America Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. North America Blood Compatible Nanocoating Market Share by Country (2020-2031)
Figure 32. United States Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Canada Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Europe Blood Compatible Nanocoating Market Share by Country (2020-2031)
Figure 36. Germany Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. France Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. U.K. Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Italy Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Russia Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Ireland Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Blood Compatible Nanocoating Market Share by Region (2020-2031)
Figure 44. China Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Japan Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. South Korea Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. India Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Australia & New Zealand Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Latin America Blood Compatible Nanocoating Market Share by Country (2020-2031)
Figure 52. Mexico Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Brazil Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Middle East & Africa Blood Compatible Nanocoating Market Share by Country (2020-2031)
Figure 56. Israel Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. UAE Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 59. Surmodics Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 60. Hemoteq AG (Freudenberg) Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 61. Biocoat Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 62. Covalon Technologies Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 63. Nanova Biomaterials Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 64. DSM Biomedical Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 65. NANOCOAT Medical Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 66. Harland Medical Systems Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 67. Daikin Industries Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 68. Applied Medical Coatings Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global Blood Compatible Nanocoating Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Inorganic Nanocoatings
Table 3. Key Players of Polymeric Nanocoatings
Table 4. Key Players of Hybrid or Composite Nanocoatings
Table 5. Global Blood Compatible Nanocoating Market Size Growth Rate by Functional Property (US$ Million): 2020 VS 2024 VS 2031
Table 6. Key Players of Antithrombogenic
Table 7. Key Players of Anti-Fouling
Table 8. Key Players of Antimicrobial
Table 9. Global Blood Compatible Nanocoating Market Size Growth Rate by Application Area (US$ Million): 2020 VS 2024 VS 2031
Table 10. Key Players of Cardiovascular Devices
Table 11. Key Players of Renal & Dialysis Devices
Table 12. Key Players of Neurovascular Implants
Table 13. Key Players of Orthopedic Implants
Table 14. Key Players of Catheters & Guidewires
Table 15. Key Players of Surgical/Extracorporeal Devices
Table 16. Global Blood Compatible Nanocoating Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Blood Compatible Nanocoating Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Blood Compatible Nanocoating Market Size by Region (2020-2025) & (US$ Million)
Table 19. Global Blood Compatible Nanocoating Market Share by Region (2020-2025)
Table 20. Global Blood Compatible Nanocoating Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 21. Global Blood Compatible Nanocoating Market Share by Region (2026-2031)
Table 22. Blood Compatible Nanocoating Market Trends
Table 23. Blood Compatible Nanocoating Market Drivers
Table 24. Blood Compatible Nanocoating Market Challenges
Table 25. Blood Compatible Nanocoating Market Restraints
Table 26. Global Blood Compatible Nanocoating Revenue by Players (2020-2025) & (US$ Million)
Table 27. Global Blood Compatible Nanocoating Market Share by Players (2020-2025)
Table 28. Global Top Blood Compatible Nanocoating Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Compatible Nanocoating as of 2024)
Table 29. Ranking of Global Top Blood Compatible Nanocoating Companies by Revenue (US$ Million) in 2024
Table 30. Global 5 Largest Players Market Share by Blood Compatible Nanocoating Revenue (CR5 and HHI) & (2020-2025)
Table 31. Global Key Players of Blood Compatible Nanocoating, Headquarters and Area Served
Table 32. Global Key Players of Blood Compatible Nanocoating, Product and Application
Table 33. Global Key Players of Blood Compatible Nanocoating, Date of Enter into This Industry
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Blood Compatible Nanocoating Market Size by Type (2020-2025) & (US$ Million)
Table 36. Global Blood Compatible Nanocoating Revenue Market Share by Type (2020-2025)
Table 37. Global Blood Compatible Nanocoating Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 38. Global Blood Compatible Nanocoating Revenue Market Share by Type (2026-2031)
Table 39. Global Blood Compatible Nanocoating Market Size by Application (2020-2025) & (US$ Million)
Table 40. Global Blood Compatible Nanocoating Revenue Market Share by Application (2020-2025)
Table 41. Global Blood Compatible Nanocoating Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 42. Global Blood Compatible Nanocoating Revenue Market Share by Application (2026-2031)
Table 43. North America Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. North America Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)
Table 45. North America Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)
Table 46. Europe Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Europe Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)
Table 48. Europe Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)
Table 49. Asia-Pacific Blood Compatible Nanocoating Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 50. Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2020-2025) & (US$ Million)
Table 51. Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2026-2031) & (US$ Million)
Table 52. Latin America Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 53. Latin America Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)
Table 54. Latin America Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)
Table 55. Middle East & Africa Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 56. Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)
Table 57. Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)
Table 58. Surmodics Company Details
Table 59. Surmodics Business Overview
Table 60. Surmodics Blood Compatible Nanocoating Product
Table 61. Surmodics Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 62. Surmodics Recent Development
Table 63. Hemoteq AG (Freudenberg) Company Details
Table 64. Hemoteq AG (Freudenberg) Business Overview
Table 65. Hemoteq AG (Freudenberg) Blood Compatible Nanocoating Product
Table 66. Hemoteq AG (Freudenberg) Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 67. Hemoteq AG (Freudenberg) Recent Development
Table 68. Biocoat Company Details
Table 69. Biocoat Business Overview
Table 70. Biocoat Blood Compatible Nanocoating Product
Table 71. Biocoat Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 72. Biocoat Recent Development
Table 73. Covalon Technologies Company Details
Table 74. Covalon Technologies Business Overview
Table 75. Covalon Technologies Blood Compatible Nanocoating Product
Table 76. Covalon Technologies Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 77. Covalon Technologies Recent Development
Table 78. Nanova Biomaterials Company Details
Table 79. Nanova Biomaterials Business Overview
Table 80. Nanova Biomaterials Blood Compatible Nanocoating Product
Table 81. Nanova Biomaterials Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 82. Nanova Biomaterials Recent Development
Table 83. DSM Biomedical Company Details
Table 84. DSM Biomedical Business Overview
Table 85. DSM Biomedical Blood Compatible Nanocoating Product
Table 86. DSM Biomedical Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 87. DSM Biomedical Recent Development
Table 88. NANOCOAT Medical Company Details
Table 89. NANOCOAT Medical Business Overview
Table 90. NANOCOAT Medical Blood Compatible Nanocoating Product
Table 91. NANOCOAT Medical Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 92. NANOCOAT Medical Recent Development
Table 93. Harland Medical Systems Company Details
Table 94. Harland Medical Systems Business Overview
Table 95. Harland Medical Systems Blood Compatible Nanocoating Product
Table 96. Harland Medical Systems Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 97. Harland Medical Systems Recent Development
Table 98. Daikin Industries Company Details
Table 99. Daikin Industries Business Overview
Table 100. Daikin Industries Blood Compatible Nanocoating Product
Table 101. Daikin Industries Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 102. Daikin Industries Recent Development
Table 103. Applied Medical Coatings Company Details
Table 104. Applied Medical Coatings Business Overview
Table 105. Applied Medical Coatings Blood Compatible Nanocoating Product
Table 106. Applied Medical Coatings Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)
Table 107. Applied Medical Coatings Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Blood Compatible Nanocoating Picture
Figure 2. Global Blood Compatible Nanocoating Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Blood Compatible Nanocoating Market Share by Type: 2024 VS 2031
Figure 4. Inorganic Nanocoatings Features
Figure 5. Polymeric Nanocoatings Features
Figure 6. Hybrid or Composite Nanocoatings Features
Figure 7. Global Blood Compatible Nanocoating Market Size Comparison by Functional Property (2020-2031) & (US$ Million)
Figure 8. Antithrombogenic Features
Figure 9. Anti-Fouling Features
Figure 10. Antimicrobial Features
Figure 11. Global Blood Compatible Nanocoating Market Size Comparison by Application Area (2020-2031) & (US$ Million)
Figure 12. Cardiovascular Devices Features
Figure 13. Renal & Dialysis Devices Features
Figure 14. Neurovascular Implants Features
Figure 15. Orthopedic Implants Features
Figure 16. Catheters & Guidewires Features
Figure 17. Surgical/Extracorporeal Devices Features
Figure 18. Global Blood Compatible Nanocoating Market Size by Application (2020-2031) & (US$ Million)
Figure 19. Global Blood Compatible Nanocoating Market Share by Application: 2024 VS 2031
Figure 20. Medical Device Manufacturers Case Studies
Figure 21. R&D and Material Companies Case Studies
Figure 22. Hospitals & Research Institutes Case Studies
Figure 23. Blood Compatible Nanocoating Report Years Considered
Figure 24. Global Blood Compatible Nanocoating Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 25. Global Blood Compatible Nanocoating Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 26. Global Blood Compatible Nanocoating Market Share by Region: 2024 VS 2031
Figure 27. Global Blood Compatible Nanocoating Market Share by Players in 2024
Figure 28. Global Blood Compatible Nanocoating Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 29. The Top 10 and 5 Players Market Share by Blood Compatible Nanocoating Revenue in 2024
Figure 30. North America Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. North America Blood Compatible Nanocoating Market Share by Country (2020-2031)
Figure 32. United States Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Canada Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Europe Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Europe Blood Compatible Nanocoating Market Share by Country (2020-2031)
Figure 36. Germany Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. France Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. U.K. Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Italy Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Russia Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Ireland Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Blood Compatible Nanocoating Market Share by Region (2020-2031)
Figure 44. China Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Japan Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. South Korea Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. India Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Australia & New Zealand Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Latin America Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Latin America Blood Compatible Nanocoating Market Share by Country (2020-2031)
Figure 52. Mexico Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Brazil Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Middle East & Africa Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Middle East & Africa Blood Compatible Nanocoating Market Share by Country (2020-2031)
Figure 56. Israel Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 58. UAE Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 59. Surmodics Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 60. Hemoteq AG (Freudenberg) Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 61. Biocoat Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 62. Covalon Technologies Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 63. Nanova Biomaterials Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 64. DSM Biomedical Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 65. NANOCOAT Medical Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 66. Harland Medical Systems Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 67. Daikin Industries Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 68. Applied Medical Coatings Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232